Inogen, Inc. Home

Lastest Financial Results

May 7, 2026 • 4:05 PM EDT

Q1 2026 Quarterly Results

Quarter Ended Mar 31, 2026

Earnings Release
PDF HTML
Audio
Earnings Webcast
Supplemental Financials
PDF

Latest News

Inogen Announces First Quarter 2026 Financial Results

Read Press Release View All

Inogen to Report First Quarter 2026 Financial Results on May 7, 2026

Inogen Announces the Appointment of Vafa Jamali to Board of Directors

Inogen Announces Participation in the 25th Annual Needham Virtual Healthcare Conference

Upcoming Events

Jun 5, 2026 • 1:00pm EDT

Inogen 2026 Annual Meeting of Shareholders

View Event View All Events

Latest Presentation

2026-02-24

Company Overview

Download View All

Latest Financial Results

Q1 2026

Quarter Ended Mar 31, 2026

$85M+ Total first quarter 2026 revenue of $85.1 million
$(1.4)M Total first quarter 2026 adjusted EBITDA of $(1.4) million
$111M+ Cash, cash equivalents, marketable securities, and restricted cash were $111.5 million as of March 31, 2026, with no debt outstanding

For complete information regarding our financials, see our periodic filings

Annual Reports & Proxy Statements

2025 Annual Report Inogen 2026 Proxy Statement

Inogen 2026 Annual Meeting of Shareholders

June 5, 2026 • 1:00pm EDT

Sign up for Email Alerts

Give Me Alerts

Stock Information

Inogen, Inc.

View Presentation

About Inogen

Inogen, Inc. (Nasdaq: INGN) is a leading global medical technology company offering innovative respiratory products for use in the homecare setting. Inogen supports patient respiratory care by developing, manufacturing, and marketing innovative best-in-class respiratory therapy devices used to deliver care to patients suffering from chronic respiratory conditions. Inogen partners with patients, prescribers, home medical equipment providers, and distributors to make its respiratory therapy products widely available, allowing patients the chance to manage the impact of their disease.

View Company Profile

2025 Revenue Breakdown

2024 Revenue Breakdown

Products

Inogen Rove 6® product image

Inogen Rove 6®

  • 6 pulse dose settings
  • 4.8 pounds
  • Battery life up to 12 hours and 45 minutes
  • Technology clinically validated for 24/7 use
  • Meets FAA requirements
Inogen® Rove 4™ product image

Inogen® Rove 4™

  • 4 pulse dose settings
  • 2.9 pounds with standard battery
  • Battery life up to 5 hours and 45 minutes with extended battery
  • Meets FAA requirements1
  • Technology clinically validated for 24/7 use2

1. Based on Technical Performance Data. Check with your carrier for local regulations.
2. With access to power

Inogen® Voxi™ 5 product image

Inogen® Voxi™ 5

  • Up to 5 liters per minute, continuous flow
  • Compact at 16.7in high
  • Caster wheels for movement at Home
  • Quiet at 45 dBA on flow setting 2
Inogen At Home® product image

Inogen At Home®

  • 5 liters per minute, continuous flow
  • Only 18 pounds
  • Extremely quiet
  • Energy-efficient
  • Only 100W on Flow Setting 2

A Team Built for Success

Our leadership team is focused on strengthening the Inogen brand via expanding awareness of our innovative solutions as well as growing across our consumer and business sales channels.

View Management Team View Board of Directors